ATE500833T1 - Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen - Google Patents

Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen

Info

Publication number
ATE500833T1
ATE500833T1 AT06291166T AT06291166T ATE500833T1 AT E500833 T1 ATE500833 T1 AT E500833T1 AT 06291166 T AT06291166 T AT 06291166T AT 06291166 T AT06291166 T AT 06291166T AT E500833 T1 ATE500833 T1 AT E500833T1
Authority
AT
Austria
Prior art keywords
preventing
cerebral edema
treating cerebral
alkyl
etifoxine
Prior art date
Application number
AT06291166T
Other languages
English (en)
Inventor
Guern Marie-Emmanuelle Le
Philippe Girard
Jean-Marie Gillardin
Laurence Berthon-Cedille
Bernard Hublot
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Application granted granted Critical
Publication of ATE500833T1 publication Critical patent/ATE500833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06291166T 2005-07-19 2006-07-18 Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen ATE500833T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0507649A FR2888749B1 (fr) 2005-07-19 2005-07-19 Composition pharmaceutique destinee a la prevention ou au traitement des oedemes cerebraux

Publications (1)

Publication Number Publication Date
ATE500833T1 true ATE500833T1 (de) 2011-03-15

Family

ID=35998401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291166T ATE500833T1 (de) 2005-07-19 2006-07-18 Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen

Country Status (5)

Country Link
US (1) US7569565B2 (de)
EP (1) EP1745785B1 (de)
AT (1) ATE500833T1 (de)
DE (1) DE602006020525D1 (de)
FR (1) FR2888749B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039453A1 (en) * 2006-03-20 2008-02-14 David Putman Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use
WO2007109289A1 (en) * 2006-03-20 2007-09-27 Xytis Inc. Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
FR2937552B1 (fr) * 2008-10-27 2011-05-06 Biocodex Composition pharmaceutique destinee a la prevention ou au traitement du syndrome de sevrage alcoolique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670772C3 (de) 1966-11-24 1978-04-20 Hoechst Ag, 6000 Frankfurt 4H-3,1-Benzoxazin-Derivate, deren Salze und pharmazeutische Präparate
DE3439055A1 (de) * 1984-10-25 1986-04-30 Hoechst Ag, 6230 Frankfurt Substituierte 4h-3,1 benzoxazine und ein benzodiazepin-derivat enthaltendes arzneimittel
JP2006523638A (ja) * 2003-04-16 2006-10-19 エフ．ホフマン−ラ　ロシュ　アーゲー キナゾリン化合物

Also Published As

Publication number Publication date
US20070021415A1 (en) 2007-01-25
FR2888749B1 (fr) 2007-10-12
EP1745785A1 (de) 2007-01-24
EP1745785B1 (de) 2011-03-09
FR2888749A1 (fr) 2007-01-26
DE602006020525D1 (de) 2011-04-21
US7569565B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
MX340965B (es) Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular.
BR0116299A (pt) Composto, composição farmacêutica, método para o tratamento ou profilaxia de uma infecção picornaviral em um mamìfero, e, uso de um composto
NO20052130L (no) Sterk inhibitor for HCV-serin-protease
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
ATE457988T1 (de) A2a-adenosin-rezeptor-antagonisten
GEP20094723B (en) Tetraazabenzo [e] azulene derivatives and analogs thereof
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
TW200420549A (en) Thiazole derivatives
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
BR0315580A (pt) Derivados de metileno uréia
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
ATE427941T1 (de) Thiazolderivate mit vap-1-hemmender wirkung
IL184116A0 (en) Use of thiazolidinone derivatives as antiangiogenic agents
BR0211171A (pt) Compostos quìmicos
BRPI0409818A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
BRPI0409881A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BRPI0508079A (pt) composto ou uma forma cristalina ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos de tratar ou prevenir uma infecção viral com hepatite c em um mamìfero e de inibir replicação de um vìrus da hepatite c
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
ATE500833T1 (de) Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen
ATE405267T1 (de) Benzoxazine zur vorbeugung oder behandlung der durch morphinderivaten verursachte hyperalgesia
BRPI0415546A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties